Infant Bacterial Therapeutics AB
IBT-B.ST
#9572
Rank
C$71.27 M
Marketcap
$5.29
Share price
-0.75%
Change (1 day)
-56.28%
Change (1 year)

Revenue for Infant Bacterial Therapeutics AB (IBT-B.ST)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Infant Bacterial Therapeutics AB from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A-100%
2017 C$0.03 M